Phase 3 Randomized Trial Support High Intensity Conditioning with Myeloablative Regimens in AML

Phase 3 Randomized Trial Support High Intensity Conditioning with Myeloablative Regimens in AML

User Photo
ASHReport

4 years
375 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Navneet Majhail, MD Director of the Blood and Marrow Transplant Program Cleveland Clinic discusses a Phase 3 Randomized Trial Support High Intensity Conditioning with Myeloablative Regimens in AML
Up Next Autoplay